Organization of Opioid Receptors in Human Brain and Drug Interactions Studied by PET and SPECT Imaging: Implications for Treatment Strategies for Opiate Addiction

Matthes, 1996, Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene, Nature, 383, 819, 10.1038/383819a0 Meunier, 1995, Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor [see comments], Nature, 377, 532, 10.1038/377532a0 Mollereau, 1996, Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene, Proc. Natl. Acad. Sci. USA, 93, 8666, 10.1073/pnas.93.16.8666 Mollereau, 1994, ORL1, a novel member of the opioid receptor family: Cloning, functional expression and localization, FEBS Lett., 341, 33, 10.1016/0014-5793(94)80235-1 Bailey, 1994, Performance comparison of a state-of-the-art neuro-SPET scanner and a dedicated neuro-PET scanner, Eur. J. Nucl. Med., 21, 381, 10.1007/BF00171411 Pike, 1993, Positron-emitting radioligands for studiesin vivo, J. Psychopharmacol., 7, 139, 10.1177/026988119300700202 Cunningham, 1994, Radioligand studies in brain: Kinetic analysis of PET data, Med. Chem. Res., 5, 79 Mintun, 1984, A quantitative model for thein vivo, Ann. Neurol., 15, 217, 10.1002/ana.410150302 Delforge, 1995, Quantification of benzodiazepine receptors in human brain using PET, [11, J. Cereb. Blood Flow Metab., 15, 284, 10.1038/jcbfm.1995.34 Frey, 1991, Parametricin vivo, Ann. Neurol., 30, 663, 10.1002/ana.410300506 Gunn, 1997, Parametric imaging of ligand–receptor binding in PET using a simplified reference region model, NeuroImage, 10.1006/nimg.1997.0303 Cunningham, 1993, Spectral analysis of dynamic PET studies, J. Cereb. Blood Flow Metab., 13, 15, 10.1038/jcbfm.1993.5 Lassen, 1992, Neuroreceptor quantitationin vivo, J. Cereb. Blood Flow Metab., 12, 709, 10.1038/jcbfm.1992.101 Frost, 1985, Imaging opiate receptors in the human brain by positron tomography, J. Comput. Assist. Tomogr., 9, 231, 10.1097/00004728-198503000-00001 Sadzot, 1990, Pain and opiate receptors: Considerations for the design of positron emission tomography studies, Anesth. Prog., 37, 113 Richards, 1985, In vivo, Eur. J. Pharmacol., 114, 343, 10.1016/0014-2999(85)90379-6 Jones, 1988, Regional cerebral opioid receptor studies with [11C]diprenorphine in normal volunteers, J. Neurosci. Methods, 23, 121, 10.1016/0165-0270(88)90184-7 Jones, 1985, New labeled ligand for in-vivo studies of opioid physiology, Lancet, 665, 10.1016/S0140-6736(85)90028-5 Hartvig, 1990, Regional distribution of the opioid receptor agonistN11, Pharmacol. Toxicol., 66, 37, 10.1111/j.1600-0773.1990.tb00698.x Hartvig, 1984, Kinetics of11, J. Pharmacol. Exp. Ther., 230, 250 Cohen, 1988, 18, J. Nucl. Med., 29, 796 Theodore, 1992, PET imaging of opiate receptor binding in human epilepsy using [18, Epilepsy Res., 13, 129, 10.1016/0920-1211(92)90068-5 Frost, 1993, Imaging delta opioid receptors in man byN11, J. Nucl. Med., 34, 103P Smith, 1994, Tracer kinetic analysis of the delta-opioid antagonistN11, J. Nucl. Med., 35, 67P Madar, 1994, Alterations in delta opioid receptors in temporal lobe epilepsy demonstrated by PET: Comparison with mu opioid receptors and metabolic activity, J. Nuc. Med., 35, 31P Kinter, 1995, Synthesis of radioiodinated naltrindole analogues: Ligands for studies of delta opioid receptors, Nucl. Med. Biol., 22, 599, 10.1016/0969-8051(94)00149-E Lever, 1994, Radioiodinated 7′-iodonaltrindole: A ligand forin vitroin vivo, J. Nucl. Med., 35, 245P Galynker, 1996, Opioid receptor imaging and displacement studies with [6-O11, Nucl. Med. Biol., 23, 325, 10.1016/0969-8051(95)02087-X Bai, 1990, No-carrier-added (NCA)N18NN18N, Int. J. Rad. Appl. Instrum. B, 17, 217, 10.1016/0883-2897(90)90150-Y Lever, 1994, Evaluation of radioiodinated C6-ON, J. Nucl. Med., 35, 128P Prevett, 1994, Opiate receptors in idiopathic generalised epilepsy measured with [11, Epilepsy Res., 19, 71, 10.1016/0920-1211(94)90090-6 Bartenstein, 1993, Investigation of the opioid system in absence seizures with positron emission tomography, J. Neurol. Neurosurg. Psychiatry, 56, 1295, 10.1136/jnnp.56.12.1295 Mayberg, 1991, Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography, Ann. Neurol., 30, 3, 10.1002/ana.410300103 Jones, 1994, Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumatoid arthritis, Br. J. Rheumatol., 33, 909, 10.1093/rheumatology/33.10.909 Jones, 1991, In vivo, Neurosci. Lett., 126, 25, 10.1016/0304-3940(91)90362-W van Heerden, 1992, The effects of nitrous oxide on the endogenous opiate system, measured with PET and C-11 Carfentanil, J. Nucl. Med., 33, 883 Zubieta, 1996, Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving, Nature Med., 2, 1225, 10.1038/nm1196-1225 Frost, 1990, Comparison of [1111, J. Cereb. Blood Flow Metab., 10, 484, 10.1038/jcbfm.1990.90 Pilapil, 1987, Autoradiographic distribution of multiple classes of opioid receptor binding sites in human forebrain, Brain Res. Bull., 19, 611, 10.1016/0361-9230(87)90080-3 Cross, 1987, Subtraction autoradiography of opiate receptor subtypes in human brain, Brain Res., 418, 343, 10.1016/0006-8993(87)90101-6 Maurer, 1983, Multiple opiate receptor in human brain: an autoradiographic investigation, Life Sci., 33, 10.1016/0024-3205(83)90485-X Jones, 1994, Quantitation of [11, J. Neurosci. Methods, 51, 123, 10.1016/0165-0270(94)90002-7 Sadzot, 1991, Quantification of human opiate receptor concentration and affinity using high and low specific activity [11, J. Cereb. Blood Flow Metab., 11, 204, 10.1038/jcbfm.1991.52 Walter, 1993, Ethanol increases mu-opioid receptor binding in man measured by C-11 Carfentanil and PET, J. Nuclear Med., 34 Frost, 1988, Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy, Ann. Neurol., 23, 231, 10.1002/ana.410230304 Carson, 1993, Comparison of bolus and infusion methods for receptor quantitation: Application to [18, J. Cereb. Blood Flow Metab., 13, 24, 10.1038/jcbfm.1993.6 Jones, 1991, Sites of action of morphine in the brain, Lancet, 338, 825, 10.1016/0140-6736(91)90717-4 Berman, 1995, Imaging pain in humans, British J. Anaesthesia, 75, 209, 10.1093/bja/75.2.209 Burn, 1995, Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11, Brain, 118, 951, 10.1093/brain/118.4.951 Bice, 1986, Simplified detection system for neuroreceptor studies in the human brain, J. Nucl. Med., 27, 184 Villemagne, 1994, Comparison of [1111in vivo, Eur. J. Pharmacol., 257, 195, 10.1016/0014-2999(94)90712-9 Malizia, 1995, A new human (psycho)pharmacology tool: The multiple organs coincidences counter (MOCC), J. Psychopharmacol., 9, 294, 10.1177/026988119500900402 Malizia, 1996, Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: Direct measurement of drug occupancy and effects on the human brainin vivo, Neuropharmacology, 35, 1483, 10.1016/S0028-3908(96)00072-X Strain, 1992, Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers, J. Pharmacol. Exp. Ther., 261, 985 Zacny, 1992, Subjective and behavioural responses to intravenous fentanyl in healthy volunteers, Psychopharmacology, 107, 319, 10.1007/BF02245155 Farde, 1988, Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs, Arch. Gen. Psychiatry, 45, 71, 10.1001/archpsyc.1988.01800250087012